Winners ECNP Poster Awards 1999

Winners ECNP Poster Awards at the 12th ECNP Congress 1999 - London, United Kingdom:

Poster session P.1  Affective disorders and antidepressants
Poster session P.2  Psychotic disorders and antipsychotics
Poster session P.3  Anxiety disorders and anxiolytics
Poster session P.4  Degenerative and neurological disorders
Poster session P.5  Addiction
Poster session P.6  Other topics

Please note that the winners are mentioned in alphabetical order of the first author.

Poster session P.1 Affective disorders and antidepressants

Altered 5-HT2A binding sites and inositol triphosphate levels in hippocampus from depressed suicide victims
Arranz, B., Rosel, P., Cano, R., Ramirez, N., Duenas, R., Navarro, M.A., San, L., Menni, B. - Spain

Thyroid axis activity and serotonin function in major depressive episode
Duval, F., Mokrani, M.C., Bailey, P., Diep, T.S., Crocq, M.A., Macher, J.P. - France

Selective adenosine A2a receptor antagonists are potential antidepressants: evidence based on the activity of SCH 58261 and A2a knockout mice in screening procedures
El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J., Vaugeois, J.-M. - France

Fluvoxamine in combination with pindolol hastens the response of delusional depressives
Franchini, L., Zanardi, R., Gasperini, M., Smeraldi, E., Perez, J. - Italy

The lithium side effects rating scale (LISERS); development of a self-rating instrument
Haddad, P., Wieck, A., Yarrow, M., Denham, P. - United Kingdom

Rapid remission of atypical depressive symptoms with the selective oradrenalin reuptake inhibitor reboxetine in SAD patients
Hilger, E., Willeit, M., Praschak-Rieder, N., Neumeister, A., Stastny, J., Thierry, N., Kasper, S. - Austria

Plasma noradrenaline and prediction of outcome in depressive illness
Kelly, C., Johnston, T., Stevenson, M., Cooper, S.J. - United Kingdom

Opioid involvement in antidepresant-type effect of NK3 receptor agonist, senktide, in the mouse forced swimming test
Kowalczyk, M., Panocka, I., Sadowski, B., Lapo, I., Masi, M. - Poland

PET neuroimaging shows antidepressant binding primarily at serotonin uptake sites in the dorsomedial thalamus of higher "animals"
Smith, D.F., Gee, A.D., Danielsen, E., Ishizu, K., Sakoh, M., Scheel-Krüger, J., Gjedde, A. - Denmark

Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans
Vollenweider, F.X., Liechti, M.E., Gamma, A., Geyer, M.A., Hell, D., Switzerland

Poster session P.2  Psychotic disorders and antipsychotics

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with haloperidol
Boin, F., Maes, M., Bocchio Chiavetto, L., Bignotti, S., Tura, G.B., Boin, F., Racagni, G., van West, D., Kenis, G., Bosmans, E., Altamura, A.C. - Italy

Amygdala or ventral hippocampus lesions on day 7 of life in rat: an animal model of psychiatric neurodevelopmental disorders like schizophrenia
Daenen, E.W.P.M., Wolterink, G., Gerrits, M.A.F.M., Kruse, C.G., van der Heijden, J.A.M., van Ree, J.M. - The Netherlands

Tc-99 HMPAO SPECT study of regional cerebral blood flow in drug-free and olanzapine-treated schizophrenic patients
Gönül, A.S., Sofuoglu, S., Tutus, A., Kula, M., Bastürk, M., Esel, E., Aslan, S.S. - Turkey

Schizophrenic psychopathology and presynaptic dopamine synthetic activity: a positron emission tomography study with [18F] fluorodopa
Gründer, G., Davids, E., Heydari, N., Vernaleken, I., Benz, P., Schlösser, R., Andreas, J., Stoeter, P., Wong, D.F., Gjedde, A. - Germany

Is neuropeptide Y involved in the pathogenesis of disorders associated with hyperactivity of dopaminergic system?
Kask, A., Harro, J. - Estonia

Is there an association of response to haloperidol treatment with polymorphisms in the DRD2 or in the DRD3 receptor genes?
Schäfer, M., Rujescu, D., Guntermann, A., Giegling, I., Dittert, S., Möller, H.-J., Bondy, B. - Germany

Poster session P.3  Anxiety disorders and anxiolytics

Influence of the serotonin antagonist, metergoline, on anxiogenic and neuroendocrine effects of carbon dioxide in healthy volunteers
Ben-Zion, I.Z., Meiri, G., Greenberg, B.D., Murphy, D.L., Benjamin, J. - Israel

The role of 5-HT2 receptors in experimentally induced anxiety
Connell, J., Deakin, J.F.W. - United Kingdom

The mini-SPIN: a brief screening assessment for social phobia
Connor, K.M., Kobak, K., Churchill, L.E., Potts, N.L.S., Katzelnick, D., Davidson, J. - U.S.A.

Organotypic rat cerebellar slice culture as a model to analyze the molecular pharmacology of GABAa receptors
Davids, E., Hevers, W., Dämgen, K., Lüddens, H. - Germany

SSRIs revert the inhibitory effect of PKC on the 5-HT transporter in OCD
Marazziti, D., Masala, I., Baroni, S., Rossi, A., Presta, S., Giannaccini, G., Dell'Osso, L., Lucacchini, A., Cassano, G.B. - Italy

Spatial working memory in Obsessive Compulsive Disorder: a three-dimensial functional magnetic resonance imaging study
van der Wee, N., Ramsey, N., Jansma, J., van Megen, H., Westenberg, H., Kahn, R. - The Netherlands

Poster session P.4 Degenerative and neurological disorders  

Treatment with selegiline in Alzheimer disease - SPECT evaluations
Gheorghe, M.D., Grigorescu, G. - Romania

Using a combined randomized start/withdrawal design to assess propentofylline's effects on disease progression in Alzheimer's disease and vascular dementia: results of clinical studies
Kittner, B. - U.S.A.

Donepezil preserves functional status in Alzheimer's disease patients: results from a 1-year prospective placebo-controlled attrition study
Mohs, R., Doody, R., Morris, J., Ieni, J.R., Rogers, S.L., Perdomo, C.A., Pratt, R.D.- U.S.A.

Nociceptin/orphanin FQ modulates spatial learning via ORL1-receptors in rats
Ögren, S.-O., Sandin, J., Terenius, L. - Sweden 

Poster session P.5 Addiction 

Buprenorphine versus methadone maintenance for the treatment of opioid dependence
Eder, H., Fischer, G., Gombas, W., Jagsch, R., Peternell, A., Stühlinger, G., Aschauer, H.N., Kasper, S. - Austria

Impaired cognitive performance in drug-free recreational ecstasy (MDMA) users raises concern about neurotoxic brain damage
Gouzoulis-Mayfrank, E., Daumann, J., Tuchtenhagen, F., Fimm, B., Sass, H. - Germany

Effectiveness of gabapentin on the substance-oriented behaviors of alcohol-dependent detoxified outpatients
Janiri, L., Hadjichristos, A., Pozzi, G., Costantino, D., Pecora, R., de Risio, S. - Italy

Acute psychological effects of 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') are attenuated by the serotonin uptake inhibitor citalopram
Liechti, M.E., Baumann, Ch., Hell, D., Vollenweider, F.X. - Switzerland 

Poster session P.6 Other topics

Preliminary, open-label study of topiramate in rapid cycling bipolar women
Kusumakar, V., Yatham, L., Kutcher, S., O'Donovan, C. - Canada

Changes in extracellular noradrenaline induced by conditioned environmental stimuli: a microdialysis study in the freely-moving rat
McQuade, R., Stanford, S.C. - United Kingdom

Inverse agonists and constitutive 5-HT1b receptor activation by a series of mutations in its BBXXB motif
Pauwels, P.J., Wurch, T. - France

Interleukin-6 activates STAT- and MAPK-signal transduction pathways and induces de novo-protein synthesis in human neuronal cells
Schumann, G., Huell, M., Machein, U., Hocke, G., Fiebich, B.L. - Germany

Towards a more rational use of psychoactive substances in clinical practice
Zitman, F.G., van Hyfte, D.M.H., de Vries Robbé, P.F., Tjandra-Maga, T.B., van der Maas, A.A. - The Netherlands